5-aminosalicylic acid

No definition available.

Endpoint definition

FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries KELA purch., KELA reimb.

Medicine purchases: ATC A07EC02
Medicine purchases: ATC: other data required >3 instances required

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector RX_A07EC02

Extra metadata

First used in FinnGen datafreeze DF4

Summary Statistics

Key figures

All Female Male
Number of individuals 4979 2700 2279
Unadjusted prevalence (%) 1.91 1.84 2.02
Mean age at first event (years) 43.31 41.91 44.98

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.02 1.60 [1.22, 2.09] 5.8e-4 239
15 years 0.01 1.81 [1.41, 2.32] 3.4e-6 185
5 years 0.00 2.93 [2.19, 3.91] 4.1e-13 74
1 year - - - -

Correlations

Index endpoint: RX_A07EC02 – 5-aminosalicylic acid
GWS hits:

Survival analyses between endpoints

Plot

before 5-aminosalicylic acid
after 5-aminosalicylic acid

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after 5-aminosalicylic acid